Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Centre Francois Baclesse

Status: Enrolling

Conditions: Long Term Cancer Side Effects; Pelvic Gynecological Cancer; Cancer Survivorship Care Plan; Advanced Nurse Practitioner; Supportive Care in Cancer

Treatments: Other: Delivery of a personalized post-cancer plan; Other: Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse; Other: Delivery of useful information according to support care needs, concerning support care professionals in the city

Study type: Interventional

Funder types: Other

Identifiers

NCT05731661

2022-A01872-41

Details and patient eligibility

About

While the sequelae and toxicities after ovarian and endometrial cancer treatments are well described in the literature, the actual needs of patients for supportive oncology care remain poorly documented. Moreover, there is no data available to estimate the complexity of the oncological support care actions to be implemented.

It is expected that an evaluation of the needs for supportive oncology care and its organization in day hospitalization for supportive oncology care will lead to an improvement in personalized post-cancer follow-up for these patients and to an improvement in their long-term quality of life.

Enrollment: 99 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient > 18 years old
• Patient in complete remission after first-line treatment for endometrial or ovarian/fallopian tube/peritoneal cancer
• Patient having completed her initial treatment; patients with maintenance treatments are eligible
• Mastery of the French language
• Patient with a telephone line
• Patient affiliated to a social security scheme
• Signature of informed consent before any specific procedure related to the study

Exclusion criteria

• Any associated medical or psychiatric conditions that could compromise the patient's ability to participate in the study
• Patient with locoregional or metastatic recurrence
• Patient deprived of liberty, under guardianship or curatorship
• Simultaneous participation in a therapeutic clinical trial

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

99 participants in 3 patient groups

Delivery of a Personalized Post-Cancer Plan (PPAC) with a day hospitalization in supportive care

Experimental group

Treatment:

Other: Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse

Other: Delivery of a personalized post-cancer plan

Delivery of a Personalized Post-Cancer Plan (PPAC) without day hospitalization in supportive care

Active Comparator group

Treatment:

Other: Delivery of useful information according to support care needs, concerning support care professionals in the city

Other: Delivery of a personalized post-cancer plan

Observational cohort

Other group

Treatment:

Other: Delivery of a personalized post-cancer plan